Fed. Circ. Skinny Label Ruling Guides On Infringement Claims

The U.S. Court of Appeals for the Federal Circuit's June 25 opinion in Amarin Pharma Inc. v. Hikma Pharmaceuticals USA Inc. provides the court's latest direction in the application of so-called...

Already a subscriber? Click here to view full article